Screening and therapy of pulmonary hypertension in systemic sclerosis

被引：14

作者：

Bull, Todd M. ^{[1
]}

机构：

[1] Univ Colorado, Denver Hlth Sci Ctr, Div Pulmon Sci & Crit Care Med, Pulmon Hypertens Ctr, Denver, CO 80262 USA

来源：

CURRENT OPINION IN RHEUMATOLOGY | 2007年 / 19卷 / 06期

关键词：

pulmonary hypertension; scleroderma; screening; vasodilator;

D O I：

10.1097/BOR.0b013e3282ec67d4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of review Systemic sclerosis is a major risk factor for the development of pulmonary arterial hypertension. Often this disease is far advanced by the time it is detected in the individual patient, severely impacting quality of life and survival. Recent findings Therapeutic options available for patients with scleroderma-associated pulmonary arterial hypertension have increased significantly over the last few years, fueling our desire to improve early detection of disease. Summary During the course of this manuscript 1 will review the literature examining approaches towards screening for scleroderma-associated pulmonary arterial hypertension 1 will then discuss the most recent studies examining therapeutic options for patients with this disease.

引用

页码：598 / 603

页数：6

共 45 条

[1] Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma [J].

Alkotob, M. Luay ;

Soltani, Peyman ;

Sheatt, Mohammad A. ;

Katsetos, Manny C. ;

Rothfield, Naomi ;

Hager, W. David ;

Foley, Raymond J. ;

Silverman, David I. .

CHEST, 2006, 130 (01) :176-181

[2] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[3]

Baroni SS, 2006, NEW ENGL J MED, V354, P2667

[4] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[5] Prevalence of pulmonary hypertension in limited and diffuse scleroderma [J].

Battle, RW ;

Davitt, MA ;

Cooper, SM ;

Buckley, LM ;

Leib, ES ;

Beglin, PA ;

Tischler, MD .

CHEST, 1996, 110 (06) :1515-1519

[6] Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: Pulmonary Hypertension Assessment and Screening Evaluation using stress echocardiography (PHASE-1) [J].

Collins, Nicholas ;

Bastian, Bruce ;

Quiqueree, Laurent ;

Jones, Carol ;

Morgan, Renae ;

Reeves, Glenn .

EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (06) :439-446

[7] Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions [J].

Denton, C. P. ;

Humbert, M. ;

Rubin, L. ;

Black, C. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (10) :1336-1340

[8]

Denton CP, 1997, BRIT J RHEUMATOL, V36, P239

[9] Clinical differences between idiopathic and scleroderma-related pulmonary hypertension [J].

Fisher, Micah R. ;

Mathai, Stephen C. ;

Champion, Hunter C. ;

Girgis, Reda E. ;

Housten-Harris, Traci ;

Hummers, Laura ;

Krishnan, Jerry A. ;

Wigley, Fredrick ;

Hassoun, Paul M. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :3043-3050

[10] Ambrisentan therapy for pulmonary arterial hypertension [J].

Galié, N ;

Badesch, D ;

Oudiz, R ;

Simonneau, G ;

McGoon, MD ;

Keogh, AM ;

Frost, AE ;

Zwicke, D ;

Naeije, R ;

Shapiro, S ;

Olschewski, H ;

Rubin, LJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :529-535

← 1 2 3 4 5 →